Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
NCT ID:
NCT01172418
Group ID:
EG000
Title:
Thymoglobulin and Daclizumab
Description:
Group I: Our standard steroid avoidance protocol, i.e., 3 daily doses of 1 mg/kg of Thymoglobulin®, the first to be infused at surgery, accompanied by 2 doses of anti-CD25 humanized monoclonal antibody, the first also to be given at surgery, and the second 2 weeks later. (controls)
Daclizumab: used in combination with Thymoglobulin as combined induction
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
29
Serious Number At Risk:
100
Other Number Affected:
8
Other Number At Risk:
75
Study:
NCT01172418
Results Section:
NCT01172418
Adverse Events Module:
NCT01172418